Paper · 6324345
Cited by244
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,138 citations.
1 to 20 of 244
Download this page as JSON| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,981,209 | Before the Trial: Taxonomic Inference, AIDS, and the Limits of Evidence Appraisal. | J Eval Clin Pract | 2026 | https://conductscience.org/library/papers/42981209 | PubMed |
| 39,339,960 | New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs. | Viruses | 2024 | https://conductscience.org/library/papers/39339960 | PubMed |
| 38,457,490 | Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38457490 | PubMed |
| 35,962,033 | Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/35962033 | PubMed |
| 35,432,297 | Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective. | Front Immunol | 2022 | https://conductscience.org/library/papers/35432297 | PubMed |
| 35,018,404 | Past and future of HIV infection. A document based on expert opinion. | Rev Esp Quimioter | 2022 | https://conductscience.org/library/papers/35018404 | PubMed |
| 33,352,046 | Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2. | J Nat Prod | 2021 | https://conductscience.org/library/papers/33352046 | PubMed |
| 32,291,335 | The Diversity-Innovation Paradox in Science. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32291335 | PubMed |
| 30,931,130 | HIV Apheresis Tags (HIVAT) Aided Elimination of Viremia. | Mol Cell Ther | 2018 | https://conductscience.org/library/papers/30931130 | PubMed |
| 30,854,194 | 40 years of the human T-cell leukemia virus: past, present, and future. | F1000Res | 2019 | https://conductscience.org/library/papers/30854194 | PubMed |
| 28,535,293 | Invited Commentary: A Landmark Study Launched in a Public Health Maelstrom. | Am J Epidemiol | 2017 | https://conductscience.org/library/papers/28535293 | PubMed |
| 26,862,491 | Historical review of the causes of cancer. | World J Clin Oncol | 2016 | https://conductscience.org/library/papers/26862491 | PubMed |
| 26,637,462 | A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies. | J Virol | 2016 | https://conductscience.org/library/papers/26637462 | PubMed |
| 26,314,853 | Uncovering HIV-1-infected cells. | Oncotarget | 2015 | https://conductscience.org/library/papers/26314853 | PubMed |
| 25,695,040 | Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent. | Front Public Health | 2014 | https://conductscience.org/library/papers/25695040 | PubMed |
| 25,369,611 | Supportive care in patients with acute leukaemia: historical perspectives. | Blood Transfus | 2015 | https://conductscience.org/library/papers/25369611 | PubMed |
| 24,736,215 | HIV-1 latency: an update of molecular mechanisms and therapeutic strategies. | Viruses | 2014 | https://conductscience.org/library/papers/24736215 | PubMed |
| 24,286,556 | From GRID to gridlock: the relationship between scientific biomedical breakthroughs and HIV/AIDS policy in the US Congress. | J Int AIDS Soc | 2013 | https://conductscience.org/library/papers/24286556 | PubMed |
| 24,243,012 | An integrated overview of HIV-1 latency. | Cell | 2013 | https://conductscience.org/library/papers/24243012 | PubMed |
| 24,124,392 | Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy. | Clin Epidemiol | 2013 | https://conductscience.org/library/papers/24124392 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/6324345/cited_by